Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
SocialCite makes its debut at the HighWire Press meeting
Corporate presentation (april 8 2014)
Corporate presentation (april 2014)
Aeterna Zentaris
Olaratumab imc 3 g3 ottobre 2010
Clinical Trial Design Considerations for Therapeutic Cancer ...
GOG update - David Miller
Corporate Presentation October 2014
Renal cell carcinoma
GI ASCO single slide per page 1-17-15
